Day One Biopharmaceuticals Stock Market Value
| DAWN Stock | USD 13.27 0.33 2.43% |
| Symbol | Day |
Day One Biopharmaceu Price To Book Ratio
Is Day One's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Day One. If investors know Day will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Day One listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.50) | Return On Assets (0.43) | Return On Equity (0.70) |
The market value of Day One Biopharmaceu is measured differently than its book value, which is the value of Day that is recorded on the company's balance sheet. Investors also form their own opinion of Day One's value that differs from its market value or its book value, called intrinsic value, which is Day One's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Day One's market value can be influenced by many factors that don't directly affect Day One's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Day One's value and its price as these two are different measures arrived at by different means. Investors typically determine if Day One is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Day One's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Day One 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Day One's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Day One.
| 05/04/2024 |
| 06/03/2024 |
If you would invest 0.00 in Day One on May 4, 2024 and sell it all today you would earn a total of 0.00 from holding Day One Biopharmaceuticals or generate 0.0% return on investment in Day One over 30 days. Day One is related to or competes with X4 Pharmaceuticals, Inozyme PharmaInc, Acumen Pharmaceuticals, Mereo BioPharma, Terns Pharmaceuticals, Eledon Pharmaceuticals, and Hookipa Pharma. Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted thera... More
Day One Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Day One's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Day One Biopharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.07) | |||
| Maximum Drawdown | 21.23 | |||
| Value At Risk | (7.39) | |||
| Potential Upside | 6.3 |
Day One Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Day One's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Day One's standard deviation. In reality, there are many statistical measures that can use Day One historical prices to predict the future Day One's volatility.| Risk Adjusted Performance | (0.03) | |||
| Jensen Alpha | (0.32) | |||
| Total Risk Alpha | (0.52) | |||
| Treynor Ratio | (0.22) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Day One's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Day One Biopharmaceu Backtested Returns
Day One Biopharmaceu secures Sharpe Ratio (or Efficiency) of -0.0608, which denotes the company had a -0.0608% return per unit of risk over the last 3 months. Day One Biopharmaceuticals exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Day One's Mean Deviation of 3.24, variance of 18.9, and Standard Deviation of 4.35 to check the risk estimate we provide. The firm shows a Beta (market volatility) of 1.26, which means a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Day One will likely underperform. Day One Biopharmaceu has an expected return of -0.27%. Please make sure to confirm Day One Biopharmaceu value at risk, daily balance of power, as well as the relationship between the Daily Balance Of Power and price action indicator , to decide if Day One Biopharmaceu performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.61 |
Good predictability
Day One Biopharmaceuticals has good predictability. Overlapping area represents the amount of predictability between Day One time series from 4th of May 2024 to 19th of May 2024 and 19th of May 2024 to 3rd of June 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Day One Biopharmaceu price movement. The serial correlation of 0.61 indicates that roughly 61.0% of current Day One price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.61 | |
| Spearman Rank Test | 0.42 | |
| Residual Average | 0.0 | |
| Price Variance | 0.64 |
Day One Biopharmaceu lagged returns against current returns
Autocorrelation, which is Day One stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Day One's stock expected returns. We can calculate the autocorrelation of Day One returns to help us make a trade decision. For example, suppose you find that Day One has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Day One regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Day One stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Day One stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Day One stock over time.
Current vs Lagged Prices |
| Timeline |
Day One Lagged Returns
When evaluating Day One's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Day One stock have on its future price. Day One autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Day One autocorrelation shows the relationship between Day One stock current value and its past values and can show if there is a momentum factor associated with investing in Day One Biopharmaceuticals.
Regressed Prices |
| Timeline |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Day One Correlation, Day One Volatility and Day One Alpha and Beta module to complement your research on Day One. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Complementary Tools for Day Stock analysis
When running Day One's price analysis, check to measure Day One's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Day One is operating at the current time. Most of Day One's value examination focuses on studying past and present price action to predict the probability of Day One's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Day One's price. Additionally, you may evaluate how the addition of Day One to your portfolios can decrease your overall portfolio volatility.
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |
Day One technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.